Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b

Journal of Medical Virology

Volumn 53, Issue 2, 1997, Pages 118-126

  Hofgärtner, Wolfgang T ^a   Polyak, Stephen J ^a   Sullivan, Daniel G ^a   Carithers Jr , Robert L ^a   Gretch, David R ^a,b  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Gel shift analysis; Hepatitis C virus; Interferon; Interferon sensitivity determining region; NS5A gene

Indexed keywords

RECOMBINANT ALPHA INTERFERON;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; CONSENSUS SEQUENCE; GENOME; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS MUTATION;

AMINO ACID SEQUENCE; ANTIVIRAL AGENTS; DNA, VIRAL; GENES, VIRAL; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS; MOLECULAR SEQUENCE DATA; MUTATION; NORTH AMERICA; RECURRENCE; RNA, VIRAL; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; VIRAL NONSTRUCTURAL PROTEINS; VIRAL STRUCTURAL PROTEINS;

HEPATITIS C VIRUS;

EID: 1842327408     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199710)53:2<118::AID-JMV3>3.0.CO;2-C     Document Type: Article

References (43)

1. Alter HJ (1995): To C or not to C: These are the questions. Blood 85:1681-1695.
2. Ausubel FM, Brent R, Kingston E, Moore DD, Seidman JG, Smith JA, Struhl K (1991): "Current Protocols in Molecular Biology." New York: Wiley-Interscience.
3. Behrens SE, Tomei L, De Francesco R (1996): Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus. Embo Journal 15:12-22.
4. Bukh J, Miller RH, Purcell RH (1995): Genetic heterogeneity of hepatitis C virus: Quasispecies and genotypes. Seminars in Liver Disease 15:41-63.
5. Camps J, Cris'ostomo S, Garc'ia Granero M, Riezu Boj JI, Civeira MP, Prieto J (1993): Prediction of the response of chronic hepatitis C to interferon alfa: A statistical analysis of pretreatment variables. Gut 34:1714-1717.
6. Chayama K, Tsubota A, Kobayashi M, Okamoto K, Hashimoto M, Miyano Y, Koike H, Kobayashi M, Koida I, Arase Y, Saitoh S, Suzuki Y, Murashima N, Ikeda K, Kumada H (1997): Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection. Hepatology 25:745-749.
7. Chemello L, Bonetti P, Cavalletto L, Talato F, Donadon V, Casarin P, Belussi F, Frezza M, Noventa F, Pontisso P, Benvegnu L, Casarin C, Alberti A, The TriVeneto Viral Hepatitis Group (1995): Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C. The TriVeneto Viral Hepatitis Group. Hepatology 22:700-706.
8. Craxi A, Magrin S, Fabiano C, Linea C, Almasio P (1995): Host and viral features in chronic HCV infection: Relevance to interferon responsiveness. Research in Virology 146:273-278.
9. Davidson F, Simmonds P, Ferguson JC, Jarvis LM, Dow BC, Follett EA, Seed CR, Krusius T, Lin C, Medgyesi GA, Kiyokawa H, Olim G, Duraisamy G, Cuypers T, Saeed A, Teo D, Conradie J, Kew M, Lin M, Nuchaprayoon C, Ndimbie D, Yap P (1995): Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5′ non-coding region. Journal of General Virology 76:1197-1204.
10. Davis GL (1994): Prediction of response to interferon treatment of chronic hepatitis C. Journal of Hepatology 21:1-3.
11. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Jr, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, van Thiel D, Tamburro C, Lefkowitch J, Albrecht J, Meschievitz C, Ortego T, Gibas A, Hepatitis Interventional Therapy Group (1989): Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. Hepatitis Interventional Therapy Group. New England Journal of Medicine 321:1501-1506.
12. Davis GL, Lindsay K, Albrecht J, Bodenheimer HC, Jr, Balart LA, Perrillo RP, Dienstag JL, Tamburro C, Schiff ER, Carey W (1994): Clinical predictors of response to recombinant interferon-alpha treatment in patients with chronic non-A, non-B hepatitis (hepatitis C). The Hepatitis Interventional Therapy Group. Journal of Viral Hepatitis 1:55-63.
13. Di Bisceglie AM, Martin P, Kassianides C, Lisker Melman M, Murray L, Waggoner J, Goodman Z, Banks SM, Hoofnagle JH (1989): Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. New England Journal of Medicine 321:1506-1510.
14. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Izumi N, Marumo F, Sato C (1995): Comparison of fulllength sequences of interferon-sensitive and resistant hepatitis C virus 1b Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. Journal of Clinical Investigation 96:224-230.
15. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, Izumi N, Marumo F, Sato C (1996): Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. New England Journal of Medicine 334:77-81.
16. Gale MJ, Korth MJ, Tang NM, Tan S, Hopkins DA, Dever TE, Polyak SJ, Gretch DR, Katze MG (1997): Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 230:217-227.
17. Germanidis G, Pellerin M, Bastie A, Stuyver L, Duverlie G, Darthuy F, Remire J, Duval J, Dhumeaux D, Pawlotsky JM (1996): Study of the genetic heterogeneity of the NS5A region of the HCV-1b genome and evolution under interferon alpha therapy. Hepatology (Abstract 551) 24.
18. Gretch D, Corey L, Wilson J, dela Rosa C, Willson R, Carithers R, Jr, Busch M, Hart J, Sayers M, Han J (1994): Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: High-titer viremia correlates with advanced stage of disease. Journal of Infectious Disease 169:1219-1225.
19. Gretch D, Lee W, Corey L (1992): Use of aminotransferase, hepatitis C antibody and hepatitis C polymerase chain reaction RNA assays to establish the diagnosis of hepatitis C virus infection in a diagnostic virology laboratory. Journal of Clinical Microbiology 30: 2145-2149.
20. Gretch DR, dela Rosa C, Carithers RL, Jr, Willson RA, Williams B, Corey L (1995): Assessment of hepatitis C viremia using molecular amplification technologies: Correlations and clinical implications. Annals of Internal Medicine 123:321-329.
21. Gretch DR, Polyak SJ, Wilson JJ, Carithers RL, Jr, Perkins JD, Corey L (1996): Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients. Journal of Virology 70:7622-7631.
22. Gretch DR, Wilson JJ, Carithers RL, Jr, dela Rosa C, Han JH, Corey L (1993); Detection of hepatitis C virus RNA: Comparison of onestage polymerase chain reaction (PCR) with nested-set PCR. Journal of Clinical Microbiology 31:289-291.
23. Herion D, Hoofnagle JH (1997): The interferon sensitivity determining region: All hepatitis C virus isolates are not the same. Hepatology 25:769-771.
24. Hino K, Sainokami S, Shimoda K, Iino S, Wang Y, Okamoto H, Miyakawa Y, Mayumi M (1994): Genotypes and titers of hepatitis b virus for predicting response to interferon in patients with chronic hepatitis C. Journal of Medical Virology 42:299-305.
25. Kanai K, Kako M, Okamoto H ( 1992): HCV genotypes in chronic hepatitis C and response to interferon. Lancet 339:1543.
26. Kolykhalov AA, Agapov EV, Rice CM (1994): Specificity of the hepatitis C virus NS3 serine protease: Effects of substitutions at the 3/4A, 4A/4B, 4B/5A, and 5A/5B cleavage sites on polyprotein processing. Journal of Virology 68:7525-7533.
27. Lam NP, DeGuzman LJ, Pitrak D, Layden TJ (1994): Clinical and histologic predictors of response to interferon-alpha in patients with chronic hepatitis C viral infection. Digestive Disease Science 39:2660-2664.
28. Lau JY, Davis GL, Kniffen J, Qian KP, Urdea MS, Chan CS, Mizokami M, Neuwald PD, Wilber JC (1993): Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 341:1501-1504.
29. Magrin S, Craxi A, Fabiano C, Simonetti RG, Fiorentino G, Marino L, Diquattro O, Di Marco V, Loiacono O, Volpes R (1994): Hepatitis C viremia in chronic liver disease: Relationship to interferon-alpna or corticosteroid treatment. Hepatology 19:273-279.
30. Martinot Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, Degott C, Descombes I, Le Breton V, Milotova V, Benhamou J, Erlinger S (1995): Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology 22:1050-1056.
31. Mita E, Hayashi N, Hagiwara H, Ueda K, Kanazawa Y, Kasahara A, Fusamoto H, Kamada T (1994): Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer. Digestive Disease Science 39:977-982.
32. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Caka T, Sato K, Tsuda F, Miyakawa Y (1992): Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources. Journal of General Virology 73:673-679.
33. Polyak SJ, Faulkner G, Carithers RL, Corey L, Gretch DR (1997): Characterization of hepatitis C virus quasispecies heterogeneity by gel shift analysis: Correlation with response to interferon therapy. Journal of Infectious Diseases 175:1101-1107.
34. Qu D, Li JS, Vitvitski L, Mechai S, Berby F, Tong SP, Bailly F, Wang QS, Martin JL, Tr'epo C (1994): Hepatitis C virus genotypes in France: comparison of clinical features of patients infected with HCV type I and type II. Journal of Hepatology 21:70-75.
35. Simmonds P (1995): Variability of hepatitis C virus. Hepatology 21: 570-583.
36. Squadrito G, Leone F, Sartoni M, Nalpas B, Berthelot P, Raimondo G, Pol S, Brechot C (1996): HCV NS5A mutations and response of chronic hepatitis to alpha interferon. Hepatology (Abstract) 24: 155A.
37. Takada N, Takase S, Enomoto N, Takada A, Date T (1992): Clinical backgrounds of the patients having different types of hepatitis C virus genomes. Journal of Hepatology 14:35-40.
38. Takada N, Takase S, Takada A, Date T (1993): Differences in the hepatitis C virus genotypes in different countries. Journal of Hepatology 17:277-283.
39. Tsubota A, Chayama K, Ikeda K, Yasuji A, Koida I, Saitoh S, Hashimoto M, Iwasaki S, Kobayashi M, Hiromitsu K (1994). Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection. Hepatology 19:1088-1094.
40. Weiland O, Schvarcz R, Wejstal R, Norkrans G, Fryd'en (1990): Therapy of chronic post-transfusion non-A, non-B hepatitis with interferon alfa-2b: Swedish experience. Journal of Hepatology 1:357-62.
41. Wilson JJ, Polyak SJ, Day TD, Gretch DR (1995): Characterization of simple and complex hepatitis C virus quasispecies by heteroduplex gel shift analysis: Correlation with nucleotide sequencing. Journal of General Virology 76:1763-1771.
42. Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, Higashi Y, Shibata M, Morishima T (1992): Detection of hepatitis C virus by polymerase chain reaction and response to interteron-alpha therapy: Relationship to genotypes of hepatitis C virus. Hepatology 16:293-299.
43. Zeuzem S, Lee JH, Roth WK (1997): Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa. Hepatology 25:740-744.